Market Indices
Latest News
 |
Key Points- Investors who suffered losses on their Applied Therapeutics, Inc....December 22, 2024 APLT -13.72% |
| ||
| ||
| ||
|
Price Targets
Mike Grondahl from Northland Securities issued a price target of $360.00 for SEZL on 2024-12-19 14:07:06.The adjusted price target was set to $360.00.At the time of the announcement,
December 19, 2024 SEZL 11.57%
Brooks O'Neil from Lake Street issued a price target of $26.00 for LFVN on 2024-12-19 13:17:38.The adjusted price target was set to $26.00.At the time of the announcement,
December 19, 2024 LFVN -2.88%
Derek Archila from Wells Fargo issued a price target of $9.00 for KZR on 2024-12-19 12:20:05.The adjusted price target was set to $9.00.At the time of the announcement,
December 19, 2024 KZR -1.84%
Edward White from H.C. Wainwright issued a price target of $15.00 for LRMR on 2024-12-17 11:53:00.The adjusted price target was set to $15.00.At the time of the announcement,
December 17, 2024 LRMR 0.38%
Kristen Kluska from Cantor Fitzgerald issued a price target of $8.00 for ESPR on 2024-12-17 11:36:38.The adjusted price target was set to $8.00.At the time of the announcement,
December 17, 2024 ESPR -0.23%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| TPIC TPI Composites, Inc. | 2.37
94.19% | ||||||||||||||||||
| ARQQW Arqit Quantum Inc. Warran | 1.28
58.29% | ||||||||||||||||||
| DRTSW Alpha Tau Medical Ltd. Wa | 0.32
52.02% | ||||||||||||||||||
| LTCH Latch, Inc. | 0.17
47.78% | ||||||||||||||||||
| PRLD Prelude Therapeutics Inco | 1.28
43.58% | ||||||||||||||||||
| SLDPW Solid Power Inc | 0.25
31.53% | ||||||||||||||||||
| JSPRW Jasper Therapeutics Inc | 0.23
31.20% | ||||||||||||||||||
| SJ Scienjoy Holding Corporat | 0.99
28.95% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 5.70%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW 4.29%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 5.67%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 3.27%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 2.73%